All posts by: Michael Zand

About Michael Zand

Scientists Used CRISPR to Put a GIF Inside Living DNA – MIT Technology Review

Continue reading

2017-07-12 NEWS

MIT Technology Review

Scientists Used CRISPR to Put a GIF Inside Living DNA
MIT Technology Review
They’ve used the gene-editing system CRISPR to insert a short animated image, or GIF, into the genomes of living Escherichia coli bacteria. The researchers converted the individual pixels of each image into nucleotides, the building blocks of DNA.
Scientists Can Use CRISPR to Store Images and Movies in BacteriaThe Atlantic
Scientists Upload a Galloping Horse GIF Into Bacteria With CrisprWIRED
Taking cells out to the movies with new CRISPR technologyPhys.Org
Nature.com –STAT
all 14 news articles »
Continue reading

2017-07-12 NEWS

Mitochondrial Disease News

Compound Called MITO-PIP May Have Potential as Gene Therapy for Mitochondrial Diseases
Mitochondrial Disease News
A compound that can silence a gene in a very specific manner was adapted by researchers to be used inside mitochondria — opening the possibility of manipulating genes linked to mitochondrial diseases. MITO-PIP, as the scientists call the compound

Continue reading

2017-07-12 NEWS

FDA cancer advisers OK ‘major advance’ — individualized cancer therapy
Chicago Sun-Times
Called CART, it involves removing immune cells from a patient’s blood, genetically altering them — in effect, reprogramming them to create an army of cells that can zero in on and destroy cancer cells — and then injecting them back into the patient

Continue reading

2017-07-12 NEWS

Breathing in a New Gene Therapy to Treat Pulmonary Hypertension
Newswise (press release)
Newswise — (New York, NY— July 12, 2017) Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the …

and more »

Continue reading

2017-07-12 NEWS

FDA advisers review data on potential 1st US gene therapy
Minneapolis Star Tribune
The therapy could be the first of a wave of cancer treatments custom-made to target a patient’s cancer. Called CAR-T, it involves removing immune cells from a patients’ blood, reprogramming them to create an army of attack cells and putting them back